Document is current
Any future updates will be listed below
-
Authors
Mordoh, Ana
Triviño Pardo, Juan Carlos
Carri, Ibel
Barrio, María Marcela
Mordoh, José
Aris, Mariana http://orcid.org/0000-0002-9404-5845
-
Funding
Funding for this research was provided by:
CONICET
Instituto Nacional del Cáncer (INC III, IS001946)
Fundación Sales
Fundación Cáncer
Fundación Pedro Mosoteguy
- License Information
-
More Information
Article History
Received: 14 September 2022
Accepted: 22 December 2022
First Online: 5 January 2023
Declarations
:
: The CASVAC-0401 study was carried out at the Instituto Alexander Fleming (Buenos Aires, Argentina) following the Declaration of Helsinki, and was approved by the Ethics Committee of that institution on 09/29/2014, resolution#354 (Comité de Ética en Investigación del Instituto Alexander Fleming, Buenos Aires, Argentina). All enrolled patients signed informed consent for their participation in the clinical trial as well as for the publication of their data anonymized.
: Written consent from patient#009, along with testification from a next of kin, was obtained for the publication of her data anonymized.
: The authors declare that they have no competing interests.
